US Patent 7851439 EFTU inhibitors or aminothiazoles and their uses
Patent 7851439 was granted and assigned to Novartis on December, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+125 characters)
Article
Patent abstract
Organic compounds that are useful for the treatment, prevention and/or amelioration of diseases are described.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07851439 EFTU inhibitors or aminothiazoles and their uses US Patent 7851439 EFTU inhibitors or aminothiazoles and their uses
Infobox
Patent Number
0785143900
Patent Number
785143900
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078514390
Date of Patent
December 14, 2010
0Patent Application Number
117554810
Date Filed
May 30, 2007
0Official Website
Patent Primary Examiner
Edits on 6 Oct, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078514390
Date of Patent
December 14, 2010
0Patent Application Number
117554810
Date Filed
May 30, 2007
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07851439 EFTU inhibitors or aminothiazoles and their uses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07851439
Date of patent
December 14, 2010
Patent application number
11755481
Date Filed
May 30, 2007
Patent primary examiner
Find more entities like US Patent 7851439 EFTU inhibitors or aminothiazoles and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
